Company: SCLXW
Filing Date: 2025-12-16
Form Type: S-1
Source: 0001193125-25-319720
Chunk: 240

Company: Scilex Holding Co
Filing Date: 2025-12-16
Form: S-1
Chunk 240
---
and SP-104and other discretionary costs. Although we believe such plans, if executed and coupled with the above described sources of liquidity, should provide us with financing to meet our needs, successful completion of such plans is dependent on factors outside of our control. We anticipate that we will continue to incur net losses into the foreseeable future as we support our clinical development to expand approved indications, continue our development of, and seek regulatory approvals for, our product candidates, and expand our corporate infrastructure. As a result, we have concluded that there is substantial doubt about our ability to continue as a going concern within one year after the date that the unaudited condensed consolidated financial statements are issued. See Note 2 titled “ Liquidity and Going Concern” to our unaudited condensed consolidated financial statements included elsewhere in this prospectus for additional information. Our existing cash and cash equivalents may be insufficient to enable us to fund our operating expenses, capital expenditure requirements, and to service our debt obligations (whether under the Oramed Note, the Tranche B Notes or otherwise) for at least the next 12 months. If these sources are insufficient to satisfy our liquidity requirements, we may seek to raise additional funds through equity offerings, debt financings, collaborations, government contracts or other strategic transactions. Cash Flows The following table summarizes our cash flows for each of the periods presented (in thousands):

|                                                          |     | Year Ended   
 December 31, 
 2024         |         |   |     | Year Ended   
 December 31, 
 2023         |         |   |     | Nine Months  
 Ended        
 September 30 
 2025         |         |   |     | Nine Months   
 Ended         
 September 30, 
 2024          |         |   |
|:---------------------------------------------------------|:----|:-------------|--------:|:--|:----|:-------------|--------:|:--|:----|:-------------|--------:|:--|:----|:--------------|--------:|:--|
| Cash Flow Data:                                          |     |              |         |   |     |              |         |   |     |              |         |   |     |               |         |   |
| Net cash proceeds from operating activities              |     | $            |  19,349 |   |     | $            | (20,707 | ) |     | $            |  21,287 |   |     | $             |  16,815 |   |
| Net